Effects of Low-glucose Degradation Product Solution on Peritoneal Membrane Characteristics in Peritoneal Dialysis Patients A 3-year Follow-up Study

被引:1
|
作者
Park, Jong Won [1 ]
Kang, Seok Hui [1 ]
Do, Jun Young [1 ]
机构
[1] Yeungnam Univ Hosp, Dept Internal Med, Div Nephrol, Taegu 705717, South Korea
关键词
peritoneal dialysis; dialysis solutions; glucose metabolism; epithelial-mesenchymal transition; RESIDUAL RENAL-FUNCTION; FREE-WATER TRANSPORT; MESENCHYMAL TRANSITION; CANCER ANTIGEN-125; NEUTRAL PH; FLUID; AQUAPORIN-1; TRIAL; BIOCOMPATIBILITY; CHILDREN;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction. Changes in peritoneal membrane characteristics including epithelial-mesenchymal transition are an important problem in the maintenance of peritoneal dialysis (PD). This study reports a 3-,year follow-up assessment of the effects of lowglucose degradation products (GDP) solution, including epithelialmesenchymal transition. Materials and Methods. Adult patients who received continuous ambulatory PD between April 2001 and March 2007 were identified, and those who maintained on PD with the same solution for more than 3 years were included. Patients with an initial effluent score of 3 (fibroblastoid cells dominant in overnight effluent dialysate) were excluded. The patients were divided into two groups according to the dialysate: standard and low-GDP. The following were measured: cancer antigen-125, cell score, normalized protein equivalent of nitrogen appearance, dialysate-plasma creatinin.e and sodium ratios, and residual renal function. Cell score and peritoneal equilibration test were measured at 1, 6, 12, 18, and 24 months after the initiation of PD. Results. Fifty patients were in the standard group and 76 in the low-GDP group. No significant difference in dialysate-plasma creatinine ratio was detected at baseline and at the end-point of follow-up between the two groups. Dialysate-plasma sodium ratio decreased significantly at the end-point of follow-up in the lowGDP group. Initial and follow-up cancer antigen-125 levels were higher in the low-GDP group. Multivariable analysis showed that low-GDP was associated with a higher cell score 3-free survival rate. Conclusions. The present study shows that a low-GDP solution may be associated with preserving the mesothelial cell and peritoneal membrane characteristics.
引用
收藏
页码:58 / 64
页数:7
相关论文
共 33 条
  • [1] Re: Effects of Low-glucose Degradation Product Solution on Peritoneal Membrane Characteristics in Peritoneal Dialysis Patients: a 3-year Follow-up Study
    Ahmadi, Farrokhlagha
    IRANIAN JOURNAL OF KIDNEY DISEASES, 2014, 8 (02) : 158 - 160
  • [2] Neutral pH and low-glucose degradation product dialysis fluids induce major early alterations of the peritoneal membrane in children on peritoneal dialysis
    Schaefer, Betti
    Bartosova, Maria
    Macher-Goeppinger, Stephan
    Sallay, Peter
    Voros, Peter
    Ranchin, Bruno
    Vondrak, Karel
    Ariceta, Gema
    Zaloszyc, Ariane
    Bayazit, Aysun K.
    Querfeld, Uwe
    Cerkauskiene, Rimante
    Testa, Sara
    Taylan, Christina
    VandeWalle, Johan
    Yap, YokChin
    Krmar, Rafael T.
    Buescher, Rainer
    Muhlig, Anne K.
    Drozdz, Dorota
    Caliskan, Salim
    Lasitschka, Felix
    Fathallah-Shaykh, Sahar
    Verrina, Enrico
    Klaus, Gunter
    Arbeiter, Klaus
    Bhayadia, Raj
    Melk, Anette
    Romero, Philipp
    Warady, Bradley A.
    Schaefer, Franz
    Ujszaszi, Akos
    Schmitt, Claus Peter
    KIDNEY INTERNATIONAL, 2018, 94 (02) : 419 - 429
  • [3] Effects of neutral pH and low-glucose degradation product-containing peritoneal dialysis fluid on systemic markers of inflammation and endothelial dysfunction: a randomized controlled 1-year follow-up study
    Park, Sun-Hee
    Do, Jun-Young
    Kim, Yeong Hoon
    Lee, Ho Yung
    Kim, Beom Seok
    Shin, Sug-Kyun
    Kim, Hyun Chul
    Chang, Yoon-Kyung
    Yang, Jong-Oh
    Chung, Hyun-Chul
    Kim, Chan-Duck
    Lee, Won Kee
    Kim, Jong-Yeon
    Kim, Yong-Lim
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (03) : 1191 - 1199
  • [4] The benefits of peritoneal dialysis (PD) solution with low-glucose degradation product in residual renal function and dialysis adequacy in PD patients: A meta-analysis
    Chen, Sheng
    Jia, Jieshuang
    Guo, Huimin
    Zhu, Nan
    INVESTIGACION CLINICA, 2022, 63 (03): : 283 - 303
  • [5] Effect of Neutral pH and Low-Glucose Degradation Product-Containing Peritoneal Dialysis Solution on Residual Renal Function in Peritoneal Dialysis Patients: A Meta-Analysis
    Wang, Jialin
    Zhu, Nan
    Yuan, Weijie
    NEPHRON, 2015, 129 (03) : 155 - 163
  • [6] The effect of low glucose degradation product, neutral pH versus standard peritoneal dialysis solutions on peritoneal membrane function: the balANZ trial
    Johnson, David W.
    Brown, Fiona G.
    Clarke, Margaret
    Boudville, Neil
    Elias, Tony J.
    Foo, Marjorie W. Y.
    Jones, Bernard
    Kulkarni, Hemant
    Langham, Robyn
    Ranganathan, Dwarakanathan
    Schollum, John
    Suranyi, Michael G.
    Tan, Seng H.
    Voss, David
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (12) : 4445 - 4453
  • [7] ASSOCIATIONS BETWEEN PERITONEAL GLUCOSE EXPOSURE, GLUCOSE DEGRADATION PRODUCT EXPOSURE, AND PERITONEAL MEMBRANE TRANSPORT CHARACTERISTICS IN PERITONEAL DIALYSIS PATIENTS: SECONDARY ANALYSIS OF THE balANZ TRIAL
    Nataatmadja, Melissa S.
    Johnson, David W.
    Pascoe, Elaine M.
    Darssan, Darsy
    Hawley, Carmel M.
    Cho, Yeoungjee
    PERITONEAL DIALYSIS INTERNATIONAL, 2018, 38 (05): : 349 - 355
  • [8] Economic Evaluation of Neutral-pH, Low-Glucose Degradation Product Peritoneal Dialysis Solutions Compared With Standard Solutions: A Secondary Analysis of the balANZ Trial
    Howard, Kirsten
    Hayes, Alison
    Cho, Yeoungjee
    Cass, Alan
    Clarke, Margaret
    Johnson, David W.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2015, 65 (05) : 773 - 779
  • [9] NEUTRAL SOLUTION LOW IN GLUCOSE DEGRADATION PRODUCTS IS ASSOCIATED WITH LESS PERITONEAL FIBROSIS AND VASCULAR SCLEROSIS IN PATIENTS RECEIVING PERITONEAL DIALYSIS
    Kawanishi, Kunio
    Honda, Kazuho
    Tsukada, Misao
    Oda, Hideaki
    Nitta, Kosaku
    PERITONEAL DIALYSIS INTERNATIONAL, 2013, 33 (03): : 242 - 251
  • [10] Efficacy and safety of febuxostat in peritoneal dialysis patients with hyperuricemia: a pilot study with one year follow-up
    Wang, Ling
    Yu, Haibo
    Liu, Xinying
    Song, Yaxiang
    Tang, Yongjing
    Bao, Hui
    Chen, Fei
    Peng, Ai
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (01): : 192 - 200